S. Ganapathy-Kanniappan, J.F. Geschwind, Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol. Cancer 12, 152 (2013)

Article  PubMed  PubMed Central  Google Scholar 

N.S. Chandel, Glycolysis. Cold Spring Harb. Perspect. Biol. 13(5 2021)

E. Enzo, G. Santinon, A. Pocaterra et al., Aerobic glycolysis tunes YAP/TAZ transcriptional activity. Embo J. 34(10), 1349–1370 (2015)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Paul, S. Ghosh, S. Kumar, Tumor glycolysis, an essential sweet tooth of tumor cells. Semin. Cancer Biol. 86(Pt 3), 1216–1230 (2022)

Article  CAS  PubMed  Google Scholar 

R.P. Brandes, F. Rezende, Glycolysis and inflammation: partners in crime! Circ. Res. 129(1), 30–32 (2021)

Article  CAS  PubMed  Google Scholar 

Y. Yuan, G. Fan, Y. Liu et al., The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis. Cell. mol.Immunol. 19(4), 504–515 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

X. Chen, N. Sun, R. Li et al., Targeting HLA-F suppresses the proliferation of glioma cells via a reduction in hexokinase 2-dependent glycolysis. Int. J. Biol. Sci. 17(5), 1263–1276 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Z. Ren, J. Zhao, S. Li, H. Yuan, Targeting Glucose Transporter 1 (GLUT1) in cancer: molecular mechanisms and nanomedicine applications. Int. J. Nanomed. 20, 11859–11879 (2025)

Article  CAS  Google Scholar 

M. Akram, Mini-review on glycolysis and cancer. J. Cancer Educ. 28(3), 454–457 (2013)

Article  CAS  PubMed  Google Scholar 

L.B. Tanner, A.G. Goglia, M.H. Wei et al., Four key steps control glycolytic flux in mammalian cells. Cell. Syst. 7(1), 49–62 e8 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Zhou, M. Qi, M. Yang, Current status and future perspectives of lactate dehydrogenase detection and medical implications: a review. Biosensors (Basel) 12(12) (2022)

K.C. Patra, Q. Wang, P.T. Bhaskar et al., Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell. 24(2), 213–228 (2013)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R.B. Robey, N. Hay, Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25(34), 4683–4696 (2006)

Article  CAS  PubMed  Google Scholar 

J.E. Wilson, Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J. Exp. Biol. 206(Pt 12), 2049–2057 (2003)

Article  CAS  PubMed  Google Scholar 

J.L. Zapater, K.R. Lednovich, M.W. Khan, C.M. Pusec, B.T. Layden, Hexokinase domain-containing protein-1 in metabolic diseases and beyond. Trends Endocrinol. Metab. 33(1), 72–84 (2022)

Article  CAS  PubMed  Google Scholar 

X. Shangguan, J. He, Z. Ma et al., Sumoylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis. Nat. Commun. 12(1), 1812 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

D. Guo, Y. Meng, X. Jiang, Z. Lu, Hexokinases in cancer and other pathologies. Cell. Insight 2(1), 100077 (2023)

Article  PubMed  PubMed Central  Google Scholar 

F.M. Matschinsky, M.A. Magnuson, D. Zelent et al., The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55(1), 1–12 (2006)

Article  CAS  PubMed  Google Scholar 

D. Simcikova, D. Gardas, K. Hlozkova et al., Loss of hexokinase 1 sensitizes ovarian cancer to high-dose metformin. Cancer Metab. 9(1), 41 (2021)

Article  PubMed  PubMed Central  Google Scholar 

C.R. Amendola, J.P. Mahaffey, S.J. Parker et al., KRAS4A directly regulates hexokinase 1. Nature 576(7787), 482–486 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

K. Seiler, M. Humbert, P. Minder et al., Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions. Cell. Death Dis. 13(5), 448 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Ni, Z. Zhuang, DDX24 promotes tumor progression by mediating hexokinase-1 induced glycolysis in gastric cancer. Cell. Signal 114, 110995 (2024)

Article  CAS  PubMed  Google Scholar 

F. Ciscato, L. Ferrone, I. Masgras, C. Laquatra, A. Rasola, Hexokinase 2 in cancer: a prima donna playing multiple characters. Int. J. Mol. Sci. 22(9 2021)

J.T. Zhong, S.H. Zhou, Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma. Oncotarget 8(8), 14133–14146 (2017)

Article  PubMed  Google Scholar 

A. Wolf, S. Agnihotri, J. Micallef et al., Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J. Exp. Med. 208(2), 313–326 (2011)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Wang, F. Shao, Y. Yang et al., A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability. Cancer Commun. (lond) 42(10), 1008–1027 (2022)

Article  PubMed  Google Scholar 

D. Guo, Y. Tong, X. Jiang et al., Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha. Cell. Metab. 34(9), 1312–24 e6 (2022)

Article  CAS  PubMed  Google Scholar 

Y.M. Meng, X. Jiang, X. Zhao et al., Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities. Nat. Commun. 12(1), 6011 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

X. Liu, X. Zuo, X. Sun, X. Tian, Y. Teng, Hexokinase 2 promotes cell proliferation and tumor formation through the Wnt/beta-catenin pathway-mediated Cyclin D1/c-myc upregulation in epithelial ovarian cancer. J. Cancer 13(8), 2559–2569 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Cai, M. Yi, Y. Tan et al., Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-IotaIota. J. Exp. Clin. Cancer Res. 40(1), 190 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J.G. Pastorino, N. Shulga, J.B. Hoek, Mitochondrial binding of hexokinase II inhibits bax-induced cytochrome c release and apoptosis. J. Biol. Chem. 277(9), 7610–7618 (2002)

Article  CAS  PubMed  Google Scholar 

A. Aublin-Gex, F. Jacolin, O. Diaz et al., Tethering of hexokinase 2 to mitochondria promotes resistance of liver cancer cells to natural killer cell cytotoxicity. Eur. J. Immunol. e2350954 (2024)

G.E. Thomas, G. Egan, L. Garcia-Prat et al., The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness. Nat. Cell. Biol. 24(6), 872–884 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar